Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit) (Tables)

v3.23.1
Stockholders’ Equity (Deficit) (Tables)
6 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Warrants Outstanding

As of March 31, 2023, the following equity-classified warrants and related terms were outstanding:

 

   

Warrants

Outstanding

    Exercise Price     Expiration Date
Common stock warrants August 2021     2,827,708     $ 11.90     August 24, 2024
Underwriter warrants August 2021     50,416     $ 14.875     August 19, 2024
Chanticleer warrants     1,267       $ 819.00 -
 $ 1,274.00
    April 30, 2027 - December 17, 2028
Series C warrants     809,243     $ 44.66     October 16, 2025
Series 3 warrants     276,140     $ 4.074     August 15, 2027
Common stock warrants February 2023     27,314,814     $ 1.08     February 10, 2028
Pre-funded warrants February 2023     2,224,000     $ 0.0001     N/A
Underwriter warrants February 2023     972,222     $ 1.35     February 8, 2028
      34,475,810